Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The putative role of inflammation in the irritable bowel syndrome.

× No keyword cloud information.

21 in total

1. Mast cells in inflammatory conditions of the gastrointestinal tract.

Authors: R B HIATT; L KATZ
Journal: Am J Gastroenterol Date: 1962-05 Impact factor: 10.864

2. Symptoms of irritable bowel syndrome in ulcerative colitis in remission.

Authors: B Isgar; M Harman; M D Kaye; P J Whorwell
Journal: Gut Date: 1983-03 Impact factor: 23.059

3. Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice.

Authors: G Barbara; R De Giorgio; Y Deng; B Vallance; P Blennerhassett; S M Collins
Journal: Gastroenterology Date: 2001-06 Impact factor: 22.682

4. Changes in number of serotonin-containing cells and serotonin levels in the intestinal mucosa of rats with colitis induced by dextran sodium sulfate.

Authors: S Oshima; M Fujimura; M Fukimiya
Journal: Histochem Cell Biol Date: 1999-10 Impact factor: 4.304

5. Inflammation-induced impairment of enteric nerve function in nematode-infected mice is macrophage dependent.

Authors: F Galeazzi; E M Haapala; N van Rooijen; B A Vallance; S M Collins
Journal: Am J Physiol Gastrointest Liver Physiol Date: 2000-02 Impact factor: 4.052

6. Interstitial cells of cajal and inflammation-induced motor dysfunction in the mouse small intestine.

Authors: T Der; P Bercik; G Donnelly; T Jackson; I Berezin; S M Collins; J D Huizinga
Journal: Gastroenterology Date: 2000-12 Impact factor: 22.682

7. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors: R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal: Gut Date: 2000-12 Impact factor: 23.059

8. Increased mast cells in the irritable bowel syndrome.

Authors: M O'Sullivan; N Clayton; N P Breslin; I Harman; C Bountra; A McLaren; C A O'Morain
Journal: Neurogastroenterol Motil Date: 2000-10 Impact factor: 3.598

9. The role of psychological and biological factors in postinfective gut dysfunction.

Authors: K A Gwee; Y L Leong; C Graham; M W McKendrick; S M Collins; S J Walters; J E Underwood; N W Read
Journal: Gut Date: 1999-03 Impact factor: 23.059

10. Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome.

Authors: V A Jones; P McLaughlan; M Shorthouse; E Workman; J O Hunter
Journal: Lancet Date: 1982-11-20 Impact factor: 79.321

44 in total

Review 1. Putative therapeutic targets in the treatment of visceral hyperalgesia.

Authors: S Collins
Journal: Gut Date: 2004-03 Impact factor: 23.059

2. Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study.

Authors: Sean J Pittock; Vanda A Lennon; Carissa L Dege; Nicholas J Talley; G Richard Locke
Journal: Dig Dis Sci Date: 2010-12-23 Impact factor: 3.199

Review 3. Clinical relevance of proteinase activated receptors (pars) in the gut.

Authors: N Vergnolle
Journal: Gut Date: 2005-06 Impact factor: 23.059

Review 4. Irritable bowel syndrome and functional dyspepsia: different diseases or a single disorder with different manifestations?

Authors: Laura Noddin; Michael Callahan; Brian E Lacy
Journal: MedGenMed Date: 2005-08-29

Review 5. Functional abdominal pain.

Authors: P J Matthews; Q Aziz
Journal: Postgrad Med J Date: 2005-07 Impact factor: 2.401

10. Development of colorectal sensitization is associated with increased eosinophils and mast cells in dextran sulfate sodium-treated rats.

Authors: J M Tobin; L M D Delbridge; R Di Nicolantonio; P Bhathal
Journal: Dig Dis Sci Date: 2004-08 Impact factor: 3.199

The putative role of inflammation in the irritable bowel syndrome.